PLIANT THERAPEUTICS, INC. (PLRX) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $45.45M | -36.2% |
| 2024 | $71.19M | +12.6% |
| 2023 | $63.23M | +87.7% |
| 2022 | $33.69M | -34.8% |
| 2021 | $51.66M | +1.5% |
| 2020 | $50.88M | -40.7% |
| 2019 | $85.81M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $45.45M | -36.2% |
| 2024 | $71.19M | +12.6% |
| 2023 | $63.23M | +87.7% |
| 2022 | $33.69M | -34.8% |
| 2021 | $51.66M | +1.5% |
| 2020 | $50.88M | -40.7% |
| 2019 | $85.81M | — |